New longitudinal functional MRI data, published in Movement Disorders, showed that measurable changes in brain network ...

It'srather well accepted that CTE is associated with cumulative exposure to brain trauma. Therefore, it's reasonable to expect that people who have lower cumulative exposure to repetitive head impacts ...

The updated guideline offers evidence-graded recommendations on when to start migraine prevention, which medications to choose, and how to manage special populations.

Qure submitted a BLA to FDA and an MAA to the UK's MHRA for ifezuntirgene inilparvovec, based on 3-year phase 1/2 data showing slowed Huntington disease progression. uniQure has submitted a Biologics ...

The chair of the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery discussed the major themes, clinical ...

Among the highest-risk combinations, loneliness was represented in the highest-risk pairs, while low handgrip strength, ...

Thayne Munce, PhD, discusses the challenges and unanswered questions shaping CTE research, as well as the implications of findings from former NFL players for athletes competing today.

In recognition of SMA Awareness Month, NeurologyLive® spoke with neuromuscular experts about how multidisciplinary care is ...

Lucy Morse, MD, a movement disorders specialist at Northwestern Medicine, discussed the push toward a biological definition for Parkinson disease, newly approved therapies, and why she believes ...

The FDA was busy early this month, during the week of August 23, 2026, making a number of decisions on potential new ...

Diagnosing multiple sclerosis (MS) has changed considerably in recent years for neurologists in the field, with revised criteria now allowing clinicians to identify the disease ea ...

Findings showed that remibrutinib outperformed teriflunomide in the REMODEL-1 and REMODEL-2 phase 3 trials among adults with relapsing MS, lowering relapse rates and MRI lesions with a favorable ...